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Background: Cardiovascular disease (CVD) is the leading cause of mortality among subjects with type 2 diabetes
(T2D), and diabetic retinopathy (DR) has been associated with an increased risk for CVD. The present study was
designed to test the concept that T2D patients with DR, but without previous cardiovascular (CV) events and with
normal renal function, have an increased atherosclerotic burden compared with patients without DR.
Methods: A cross-sectional study was performed using patients with normal renal function (estimated glomerular
filtration rate (eGFR) >60 ml/min) and without previous CV events. A total of 312 patients (men, 51%; mean age,
57 yrs; age range 40–75 yrs) were included in the study; 153 (49%) of the patients had DR. B-mode carotid
ultrasound imaging was performed for all of the study subjects to measure the carotid intima-media thickness
(cIMT) and carotid plaques in the common carotid artery (CCA), bifurcation and internal carotid artery (ICA).
Results: The percentage of carotid plaques in T2D patients with DR was higher than in T2D patients without DR
(68% vs. 52.2%, p = 0.0045), and patients with DR had a higher prevalence of ≥2 carotid plaques (44.4% vs. 21.4%;
p < 0.0001). No differences were observed in the cIMT measured at different carotid regions between the patients
with or without DR. Using multivariate logistic regression (adjustment for major risk factors for atherosclerosis), DR
was independently associated with mean-internal cIMT (p = 0.0176), with the presence of carotid plaques (p = 0.0366)
and with carotid plaque burden (≥2 plaques; p < 0.0001).
Conclusions: The present study shows that DR in T2D patients without CVD and with normal renal function is
associated with a higher atherosclerotic burden (presence and number of plaques) in the carotid arteries. These
patients may be at a higher risk for future CV events; therefore, an ultrasound examination of the carotid arteries
should be considered in patients with DR for more careful and individualised CV assessment and follow-up.
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phropathy and neuropathy) and macrovascular complica-
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unless otherwise stated.Traditionally, the micro- and macrovascular complica-
tions of diabetes have been viewed, studied, and treated as
distinct and independent disorders. However, accumu-
lating data from epidemiological and pathophysiological
studies suggest that these vascular complications may
share common pathophysiological mechanisms beyond
those related to traditional cardiovascular (CV) risk
factors. Data obtained from epidemiological studies have
clearly demonstrated that diabetic retinopathy (DR), a
common chronic microvascular complication of dia-
betes, is associated with macrovascular disease [1] asThis is an Open Access article distributed under the terms of the Creative
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patients with type 2 diabetes mellitus (T2D) [2]. In these
patients, the presence of DR has been described as an
independent risk factor for incident coronary heart dis-
ease [3,4] and ischaemic stroke [5]. Among the possible
mechanisms described to explain the interconnection
between diabetic micro- and macroangiopathy are meta-
bolic disturbances [6]. Other authors have suggested that
microangiopathy of the vasa vasorum (VV), the plexus of
microvessels that partially provides oxygen and nutrients
to the walls of large arteries, may be involved in diabetic
atherosclerosis [7,8]. Our group recently reported that
T2D patients with DR had increased angiogenesis of the
VV of the common carotid artery (CCA) [9]. These find-
ings were recently confirmed by Sampson et al. in a larger
study of T2D patients [10].
When a clinical CV event occurs, atherosclerotic dis-
ease is difficult to reverse. In these cases, ultrasonog-
raphy of the carotid arteries is frequently used to detect
early signs of atherosclerosis, i.e., increased thickness of
the arterial wall or the occurrence of plaques. Ample
data suggest that plaque and carotid intima-media thick-
ness (cIMT) are associated with prevalent and incident
coronary heart disease (CHD) and stroke, with the pres-
ence of plaque generally having a stronger association
with CVD compared to cIMT alone [11]. Thus, it has
recently been demonstrated that ultrasound assessment
of a carotid plaque and its total volume or total area
progression is a stronger predictor of future CV events
than cIMT measurement [12,13]. A high prevalence
(between 43% and 64%) of carotid plaques has been de-
scribed in T2D patients without evidence of CV disease
(CVD) [14-16]. Prospective studies conducted in T2D
patients free of any CV event have shown that the per-
centage of patients with carotid artery plaques is higher
in those who develop a CV event compared with those
who are free from CV events [15,16]. Recent epidemio-
logical studies have demonstrated that chronic kidney
disease (CKD), defined as an estimated glomerular filtra-
tion rate (eGFR) <60 ml/min, is an independent risk
factor for atherosclerotic disease [17] and for the pres-
ence of carotid plaques [18]. In T2D patients, a high
prevalence of low eGFR without associated albuminuria
has been reported and described to be associated with
atherosclerosis of peripheral arteries, independently of
albuminuria, [19] and with cIMT in several [20], but not
all, studies [21,22].
To test the concept that patients with T2D and DR
have an increased prevalence of subclinical atheroscler-
osis, as shown using carotid plaque burden and cIMT
measurements, we investigated the association between
these measures and retinopathy in a group of patients
with T2D but without previous CVD and with normal
renal function.Methods
Subjects
T2D patients were selected to participate in this single-
centre study, which aimed to investigate the association
between carotid atherosclerosis and DR in T2D. All
study participants were recruited from the outpatient
clinic at our centre, and potential candidates were iden-
tified by screening patients enrolled in the diabetic eye
disease programme of our centre as well as those visiting
the diabetic retinopathy unit. The inclusion criteria for
both groups were as follows: age range, 40–75 yrs;
absence of established impaired renal function (calcu-
lated glomerular filtration rate (eGFR) <60 ml/min); and
known CVD. From the total number of subjects who
were initially recruited, 60 subjects were excluded after
the screening visit because of the presence of an exclu-
sion criterion (previous CVD, impaired renal function,
increased urine albumin excretion, or not having T2D),
and 15 additional patients withdrew from the study after
the initial screening visit (consented withdrawal before
completing the study assessment). A total of 312 parti-
cipants with (n = 153) or without (n = 159) DR were
included in the study. To achieve a uniform age distribu-
tion, patients with and without DR were selected to have
representative and similar numbers of patients by gender
and age (stratified according to 5-yr age intervals). How-
ever, we could not recruit enough patients with retinop-
athy in the age range between 40 and 50 yrs. For the
purpose of this study, a patient was arbitrarily consid-
ered to have previous hypertension or dyslipidaemia if
the patient was taking medication for the given condi-
tion. The weight, height and waist circumference of the
subjects were measured using standardised methods,
and the blood pressure (mean of 2 measurements, 5 min
apart) of the subjects was measured after 10 min in the
seated position using a blood pressure monitor (HEM-
7001E, Omron, Barcelona, Spain). The patients underwent
a complete eye evaluation by experienced ophthalmolo-
gists (AT and CJ) to assess the presence or absence
of diabetic retinopathy according to an international
clinical DR consensus [23]. Retinopathy was evaluated
using multifield stereoscopic retinal photography with
the following definitions: a) mild nonproliferative DR -
microaneurysms only; b) moderate nonproliferative
DR - more than just microaneurysms but less than se-
vere nonproliferative DR; c) severe nonproliferative DR
by any of the following - more than 20 intraretinal hae-
morrhages in each of 4 quadrants, definite venous bead-
ing in 2+ quadrants, prominent intraretinal microvascular
abnormalities in 1+ quadrant, and no signs of proliferative
retinopathy; and d) proliferative DR, by neovascularisation
and/or vitreous/preretinal haemorrhage. In addition to
the anamnestic evaluation and physical examination,
the patients’ clinical records were reviewed to rule out
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larisation procedures, including coronary heart disease,
cerebrovascular disease, or peripheral vascular disease
(including the diagnosis of diabetic foot disease). Ours
is the only reference hospital for CVDs and procedures
in the region, but we also had access to reports from
three small hospitals in the region. Therefore, along
with the anamnestic evaluation, we could ascertain any
CV events that occurred in the health-care area. Heart
failure and macroalbuminuria (urine albumin/creatinine
ratio >299 mg/g) were also considered exclusion criteria.
Serum and spot urine samples were collected in the
fasting state, and all serum and urine tests were per-
formed using standard laboratory methods. Low-density
lipoprotein cholesterol was estimated using the Friede-
wald formula, and eGFR was estimated using the diet
modification in renal disease (MDRD-4) formula [24].
Haemoglobin A1c (HbA1c) levels were determined using
HPLC (VariantTM, Bio-Rad Laboratories SA, Spain), and
its concentrations are expressed in National Glycohemo-
globin Standardization Program/Diabetes Control and
Complications Trial units. Urine albumin was measured
using an immunoturbidimetric method and a Roche/Hita-
chi Modular P analyser (Roche Diagnostics, Spain).
Carotid ultrasound imaging study
All of the study participants underwent the same carotid
ultrasound protocol. All measures and ultrasound stud-
ies were assessed by the same researcher (ER), who was
blinded to the conditions of the participants and did not
have access to the study data. B-mode ultrasound im-
aging was performed using a Siemens Sequoia 512 and
a 15-Mhz linear array probe. Moreover, a standardised
imaging protocol was performed to evaluate intima-
media-adventitia thickness (IMT), defined as the distance
between the lumen-intima and the media-adventitia ultra-
sound interfaces (intima-media complex), and plaque
presence in the carotid arteries. The patients were ex-
amined from their back; they were placed in the supine
position with the head turned 45° contralateral to the
side of scanning. Images were obtained in longitudinal
sections, with a single lateral angle of insonation and
optimisation of the image to the far wall. The B-mode
images of the left and right segments were recorded and
electronically stored. The last (previous to the bulb) and
first (starting at the flow divider) centimetres of the
common and internal carotid arteries, respectively, and
the total length of the bulb were used for IMT measure-
ments, which were performed off-line using semiauto-
matic software. The data (mean IMT and mean-maximum
IMT) from each segment were provided, and the right-
and left-side values were averaged to obtain the mean
and mean-maximum common carotid (CC), carotid
bulb, and internal carotid (ICA) measurements. Plaqueswere identified using B-mode and colour Doppler exami-
nations in both the longitudinal and transverse planes to
consider circumferential asymmetry and were defined as a
“focal structure that encroaches into the arterial lumen of
at least 0.5 mm or 50% of the surrounding cIMT value or
demonstrates a thickness of 1.5 mm, as measured from
the media adventitia interference to the intima-lumen sur-
face” according to the Mannheim consensus [25].
The local Ethics Committee of Hospital Arnau de
Vilanova (Lleida, Spain) approved the protocol, and all
of the patients signed written informed consent forms.
Sample size
To determine the sample size, we used preliminary data
from a previous study of our group in which the plaque
frequency was 69% in patients with retinopathy or 52%
in patients without retinopathy [10]. We calculated a
sample size of 126 subjects for each study group, which
would allow an 80% power to detect differences between
groups with a significance level of <0.05. Thus, the number
of patients included in each group was sufficient to test
the initial hypothesis.
Statistical analysis
The data are presented as the median values and 25th
and 75th percentiles, means ± standard deviations (SDs),
and n (%), as appropriate. Non-normally distributed
variables were log transformed to reduce skewness, and
normality was re-evaluated. Between-group (DR vs. non-
DR, male vs. female, and with hypertension vs. without
hypertension, or dyslipidaemia, or smoking habit) differ-
ences in anthropometric, clinical, cIMT, and laboratory
variables were evaluated using the chi-squared test (for
categorical variables), Wilcoxon test (for continuous, non-
normally distributed variables), or Student’s t-test (for
continuous, normally distributed variables). Unadjusted
and adjusted general linear models (PROC GLM in
SAS) were used to test whether cIMT values differed
between diabetic patients with retinopathy vs. those
without retinopathy. Univariate or multiple logistic
regression models were used to evaluate the differences
in plaque presence between the groups. The following
factors were entered into the adjusted general linear
and multiple logistic regression models: age, sex, body
mass index, presence of hypertension, presence of dysli-
pidaemia, smoking habit, urinary albumin excretion rate
and eGFR. The significance level was defined as p ≤ 0.05,
and all analyses were performed using SAS software, v. 9.2
(SAS Institute Inc., USA).
Results
Clinical variables
Among the 312 study patients with T2D, 153 (49.03%)
had DR. The patients with retinopathy were older due to
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<50 yrs. As typically observed in previous studies com-
paring patients with and without DR, the patients with
this condition had longer diabetes duration and were
more likely to receive insulin treatment and antiplatelet
agents. These patients also exhibited a higher preva-
lence of hypertension, higher systolic blood pressure,
and increased waist circumference, HbA1c level, HDL-c
level, and urinary albumin/creatinine ratio compared
with those without DR (Table 1). The distribution of
retinopathy grades was as follows: 60 patients had mild
retinopathy (39.2%), 57 patients had moderate retinop-
athy (37.3%), 29 patients had severe nonproliferative
retinopathy (18.9%), and 7 patients had severe prolifera-
tive retinopathy (4.6%).
Ultrasound examination
The mean and mean-maximum cIMT at different terri-
tories (common, bulb, and internal carotid) did not
differ between the patients with DR and those without
DR, except that a higher mean-maximum common
cIMT was observed in the patients with DR (p = 0.0187);
these differences disappeared after adjustment (Table 2).
The general linear models were used to evaluate the
cIMT determinants. Age (p < 0.0001) and active smokingTable 1 Characteristics of the study groups
Diabetes without
retinopathy (n = 1
Sex (male/female) 82/77
Non-Caucasian 7 (4.4%)
Age (yr) 59 (48–66)
Disease duration (yr) 6 (2–10)
Insulin treatment (n) 20 (12.6%)
Smoking (current/past/never) 71/54/32
Antiplatelet agents 112/47 (29.6%)
Dyslipidaemia (yes/no) 88/71 (44.7%)
Hypertension (yes/no) 83/76 (47.8%)
Systolic BP (mm Hg) 134 (123–145)
Diastolic BP (mm Hg) 76 (70–83)
HR (b/min) 75 (68–82)
Body mass index (kg/m2) 30.3 (27.4-34.0)
Waist circumference (cm) 103 (96–111)
Haemoglobin A1c (%) 7.1 (6.5-7.9)
Total cholesterol (mmol/l) 184 (163–207)
HDL-cholesterol (mmol/l) 47 (40–57)
LDL-cholesterol (mmol/l) 108 (90.2-130.2)
Triglycerides (mmol/l) 118 (89–171)
Serum creatinine (μmol/l) 0.79 (0.69-0.92)
Urinary albumin/creatinine ratio, mg/g 5.8 (3.2-11)
Data are presented as the median values and interquartile ranges. BP, blood pressu(p = 0.0641); age (p = 0.0154) and hypertension (p = 0.0140);
and age (p = 0.0131), sex (p = 0.0327), and the presence of
retinopathy (p = 0.0176) were independently associated with
mean CCA-IMT, bulb-IMT, and ICA-IMT, respectively.
No association was found between any of the cIMT
measurements at different territories or between the
UAE and eGFR values or diabetes duration.
The percentage of patients with carotid plaques was
higher in those with DR compared to those without DR
(68% vs. 52.2%, p = 0.0045), and of these patients, the
DR group contained more patients with ≥2 carotid pla-
ques (44.4% vs. 21.4%, p < 0.0001). No association was
found between carotid plaque burden (≥2 carotid plaques)
and the duration of diabetes. In relation to the territory,
there was a tendency towards a higher frequency of
plaques at the internal carotid artery (ICA) in the
group of patients with DR (36% vs. 49%, p = 0.07). The
variables that were independently associated with the
presence of carotid plaques were age (p = 0.0022),
hypertension (p = 0.0300), the presence of retinopathy
(p = 0.0366), and active smoking (p = 0.0109) (Table 3).
The variables that were associated with the presence
of ≥2 carotid plaques were age (p < 0.0001), sex (p =
0.0015), dyslipidaemia (p = 0.0031), and the presence of
retinopathy (p < 0.0001) (Table 4).59)
Diabetes with
retinopathy (n = 153)
p
76/77 0.7373
6 (4.6%) 0.9413
61 (54–68) 0.0127
11 (6–20) <0.0001
84 (54.9%) <0.0001
78/44/30 0.5134
82/71 (46.4%) 0.0022
79/74 (48.4%) 0.5111
48/105 (68.3%) 0.0002
143 (133–159) <0.0001
77.5 (68.5-85.5) 0.7526
77 (70–86) 0.0767
31.1 (28.3-35) 0.2477
107.5 (163–114) 0.0039
8.1 (7.2-9.1) <0.0001
181 (162–204.5) 0.9889
50.5 (42–60.5) 0.0308
105.4 (86.5-127.8) 0.2694
116 (83–168) 0.6181
0.79 (0.68-0.93) 0.7975
12.4 (6–32.7) <0.0001
re.
Table 2 Results of the ultrasonographic carotid study: carotid intima-media thickness and presence of carotid plaques
No retinopathy
(n = 159)
Retinopathy
(n = 153)
P value
Mean common cIMT 0.789 (0.686-0.889) 0.802 (0.731-0.907) 0.1474
Mean-max common cIMT 0.941 (0.820-1.049) 0.986 (0.889-1.073) 0.0187
Mean bulb cIMT 0.835 (0759–0.955) 0.861 (0.723-0.928) 0.6674
Mean-max bulb 1.047 (0.922-1.199) 1.007 (0.919-1.227) 0.7470
Mean-internal cIMT 0.677 (0-566-0.782) 0.623 (0.534-0.713) 0.1151
Mean-max internal cIMT 0.845 (0.704-1.009) 0.810 (0.685-0.909) 0.2070
Carotid plaques, n (%) 83 (52.2%) 104 (68%) 0.0045
Carotid plaques (none/1/>1) (n) 76/49/34 49/36/68 <0.0001
Common carotid plaque, n (%) 9 (10.8%) 19 (18.3%) 0.1574
Bulb plaque, n (%) 67 (80.7%) 89 (85.6%) 0.3752
Internal carotid plaque, n (%) 30 (36.1%) 51 (49%) 0.0771
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ence were observed among the groups with different grades
of retinopathy (mild vs. moderate/severe/proliferative).
Discussion
The present study shows that T2D patients with DR
who are free of clinical CVD and with normal renal
function have increased atherosclerotic burden in their
carotid arteries compared with patients without DR.
Epidemiological studies have demonstrated that DR in
T2D patients is associated with a 1.7-fold increased risk
of CV events, such as stroke, coronary artery disease
and heart failure [26]. Notably, this risk persists after
adjusting for traditional CV risk factors, diabetes dur-
ation and diabetes control, suggesting that microvascular
disease may contribute to the development of CVD in
diabetes. A major finding of the present study is that DR
is independently associated with the presence of carotid
plaques. This result is similar to that observed in the
study by Kreutzenberg et al., in which DR was inde-
pendently associated with carotid plaques, although theTable 3 Multivariate logistic regression for the presence
of carotid plaques
Odds ratio (95% confidence interval) P value
Age 1.04 (1.01-1.07) 0.0022
BMI 0.98 (0.93-1.03) 0.4578
Female sex 0.79 (0.47-1.34) 0.3952
DR 1.71 (1.03-2.85) 0.0366
Hypertension 1.78 (1.05-3.00) 0.0300
Dyslipidaemia 1.16 (0.71-1.89) 0.5505
Smoking 2.17 (1.13-4.14) 0.0109
eGFR 1.00 (0.99-1.01) 0.3345
UAE 0.99 (0.99-1.00) 0.6397
DR: diabetic retinopathy; UAE: urinary albumin excretion rate; eGFR: estimated
glomerular filtration rate.number of patients with retinopathy was lower in that
study than in our study, and patients with previous CV
events were not excluded [27]. On the other hand,
several studies have described an association between
cIMT thickness, as a surrogate marker of atheros-
clerosis, and DR that is independent of traditional risk
factors and glucose control [28,29]. Miyamoto et al. also
reported an association between common carotid arter-
ial diameter, as a marker of atherosclerosis, and the pres-
ence of DR [30]. It should be noted that in the present
study, the percentage of patients with carotid plaques
was not only higher in those with DR than in those
without DR but that the number of carotid plaques was
also elevated. To the best of our knowledge, there is no
report in the literature regarding atherosclerotic plaque
burden in T2D patients with or without DR. A direct
association has been described between a plaque score,
consisting of the sum of the maximum plaque thick-
nesses of different carotid territories, and the presence
and extent of coronary artery disease in T2D patients
[31]. As reported in general-population studies, the riskTable 4 Multivariate logistic regression for carotid plaque
burden (≥2 plaques)
Odds ratio (95% confidence interval) P value
Age 1.09 (1.05-1.13) <0.0001
BMI 0.98 (0.92-1.04) 0.6012
Female sex 0.36 (0.19-0.67) 0.0015
DR 3.17 (1.75-5.75) <0.0001
Hypertension 2.00 (1.08-3.70) 0.0255
Dyslipidaemia 2.32 (1.33-4.05) 0.0031
Smoking 1.62 (0.77-3.39) 0.1980
eGFR 1.00 (0.99-1.02) 0.3177
UAE 0.99 (0.98-1.00) 0.3107
DR: diabetic retinopathy; UAE: urinary albumin excretion rate; eGFR: estimated
glomerular filtration rate.
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ually increases with incremental total plaque number,
irrespective of the location of the plaques [32]. More-
over, carotid plaque measurements have been shown to
be more strongly predictive of CV events than cIMT
measurements. The extent of atherosclerosis in the
carotid artery, measured either as total plaque area [30]
or as progression of total plaque volume [12], has been
shown to be an independent predictor of coronary
events in patients with [12] and without previous CV
events [33]. Although these studies included a small
proportion of subjects with diabetes, no specific data on
these subjects were provided. In the Rotterdam study, a
direct relationship between the number of carotid terri-
tories with a carotid plaque and incident cases of myo-
cardial infarction was described [34].
Carotid plaque predominantly occurs at sites of non-
laminar turbulent flow, such as the carotid bulb and
the proximal ICA, but rarely in the CCA, except in
advanced atherosclerotic disease [35]. In the present
study, the percentage of plaques in the ICA was higher
in T2D patients with DR than in those without DR;
however, these differences were not significant. The
presence of plaques in the ICA territory is now accepted
to be associated with an increased risk of stroke (annual
risk of 0.1% to 1.9% for an ICA stenosis <75% to 80%,
and annual risk of 2.0% to 3% with greater degrees of
stenosis) [36]. Thus, considering research results sug-
gesting that CV events increase as the burden of athero-
sclerosis increases, we hypothesise that T2D patients
with DR and >1 carotid plaque will have a higher risk of
CV events. This speculation can only be answered by
conducting a prospective study assessing the future
occurrence of CV events in these patients.
As stated in almost all studies on DR, the condition is
closely related to duration of the disease, higher blood
pressure and a higher albumin excretion rate, all of
which may contribute to the increased atherosclerosis in
these patients [37]. In the present study, these factors
were also more frequent in patients with DR. However,
of these variables, only hypertension proved to be inde-
pendently associated with carotid plaques.
It is now accepted that CKD, defined as an eGFR
of <60 ml/min, is an independent risk factor for ath-
erosclerotic diseases and is associated with the pres-
ence of a carotid plaque independent of albuminuria
[38]. Recent studies have emphasised that a large num-
ber of T2D patients with low eGFR have a normal UAE
[39,40]. It should be noted that little information
regarding renal function has been reported in those
studies that analysed subclinical atherosclerosis in
patients with T2D. In this respect, the study by Saif et al.,
conducted inT2D patients with normal renal function,
did describe a correlation between DR and cIMT [29].Another ultrasound measure that is used as a surro-
gate marker for atherosclerosis is cIMT. This measure,
as described for carotid plaques, has been reported to be
associated with traditional and newer risk factors for
atherosclerosis. The cIMT baseline measures and its pro-
gression during follow-up are described to be strongly
associated with CVD events, even after adjustment for
traditional risk factors [41]. cIMT has typically been
measured in the CCA, rather than in the carotid bulb or
ICA, because high-level measurement precision is easily
obtained from this artery. However, it should be noted
that the accuracy of cIMT as a marker of atherosclerosis
has been questioned by the fact that medial hypertrophy
or intimal thickening of CCA may be influenced by fac-
tors that do not necessarily reflect the atherosclerotic
process, such as age and hypertension [42]. In the
present study, T2D patients with DR had a higher
mean-maximum common cIMT than did those without
DR, whereas no differences were observed in the
bulb-cIMT or in the internal cIMT measures between
the groups. However, DR was independently associated
with only the mean-internal cIMT. In relation to cIMT, it
is accepted that, clinically, the measurement of CCA-
cIMT is easier and more reliable compared to ICA-cIMT.
In contrast, ICA-cIMT appears to predict atherosclerotic
cardiac events better than common cIMT [43]. Thus,
including internal cIMT and traditional CV risk factors,
as well as the presence of plaque in the internal terri-
tory, improves the risk classifications of stroke and
coronary heart disease in general population studies.
The association between DR and carotid ultrasound
measurements has been analysed in large-population
cohort studies conducted on subjects without a history
of clinical CVD. The ARIC study found that the severity
of retinopathy was associated with carotid artery intima-
media wall thickness [44], while the CHS [45] and
MESA [46] studies found no association between DR
and cIMT or carotid stenosis. Possible explanations for
the different results obtained in these last two studies
and ours may be due to the difference in ethnic back-
grounds of patient groups, different criteria used for the
definition of subclinical atherosclerosis, different popula-
tion selection or the absence of bulb territory (a site
with a high prevalence of plaques) in the ultrasound
examination in these studies. In the present study, no
differences in cIMT measurements or in plaque pres-
ence were observed among the groups with different
grades of retinopathy. This finding is in contrast to the
findings of Kreutzenberg et al. [27], who described that
the retinopathy stage was associated with carotid athero-
sclerosis. Additionally, in the ARIC study, the severity of
retinopathy was associated with cIMT. However, in
contrast to the present study, patients with previous CV
events were not excluded in those studies. Moreover, the
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or in plaque presence in relation to retinopathy grades in
the present study may be due to few patients in the group
having more severe retinopathy. Thus, any conclusion
drawn from these results must be made with caution.
In relation to retinopathy and the future risk of CV
events, retinopathy has been described in population-
based samples as a risk factor (independent from dia-
betes) for stroke [47], heart failure [48] and coronary
heart disease [49]. Patients from the ARIC study who
had better CV health, according to the American Heart
Association criteria, had a lower prevalence of retinop-
athy [50]. Moreover, the presence of retinopathy and
retinal microvascular signs has recently been described
to be associated with an increased risk of cerebral micro-
vascular disease [51].
The strength of the present study is its specific design,
which aimed to test the hypothesis that T2D patients
with retinopathy have a higher atherosclerotic burden
compared with T2D patients without retinopathy. Thus,
a large number of patients with retinopathy were in-
cluded. Only those patients with an eGFR >60 ml/min
were included to avoid the confounding factor of renal
insufficiency, which is associated with an increased risk
of atherosclerosis.
The major limitation of the present study is that a
direct relationship between retinopathy and macrovascular
disease cannot be demonstrated due to the cross-sectional
nature of the study. To assess the CV risk associated with
a microvascular complication, such as DR in patients
with T2D, longitudinal studies are warranted. To prop-
erly assess the CV risk, future studies should include
T2D patients with DR (with and without carotid pla-
ques) and T2D patients without DR and other micro-
vascular complications.
Conclusions
The present study, which has been specifically designed
to test the hypothesis that T2D patients with DR who
are free of previous CVD and have normal renal func-
tion have a higher atherosclerotic burden than those
without DR, shows an association between DR and
subclinical carotid atherosclerosis. More specifically,
T2D patients with DR have an increased atherosclerotic
burden (presence of plaques and number of plaques) in
the carotid territory. Previous studies performed on the
general population have shown that individuals with an
increased atherosclerotic burden have a higher risk of
CV events (myocardial infarction and stroke). Given the
increased atherosclerotic plaque burden observed in the
T2D patients with DR in the present study, we believe
that these patients represent a target population in which
ultrasound examination of the carotid artery should
be performed to evaluate the presence/absence ofatherosclerotic lesions in this location. In our opinion,
given the association between the atherosclerotic plaque
burden and the future risk of CV events shown in general-
population studies, a more careful CV assessment and
follow-up should be considered in patients with carotid
plaques at ultrasound examination.
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